Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis.

Elsayed, Mohamed; Mohamed, Khaled A; Dardeer, Khaled T; Zaafar, Dalia K; Hassanin, Soha Osama; Abdelnaby, Ramy; Schönfeldt-Lecuona, Carlos

Elsayed, Mohamed; Mohamed, Khaled A; Dardeer, Khaled T; Zaafar, Dalia K; Hassanin, Soha Osama; Abdelnaby, Ramy; Schönfeldt-Lecuona, Carlos.

Afiliação

Elsayed M; Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.
Mohamed KA; Faculty of Medicine, Cairo University, Cairo, Egypt.
Dardeer KT; Faculty of Medicine, Cairo University, Cairo, Egypt.
Zaafar DK; Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, Egypt.
Hassanin SO; Department of Biochemistry, Faculty of Pharmacy, MTI, Cairo, Egypt.
Abdelnaby R; Department of Neurology, RWTH Aachen University, Aachen, Germany.
Schönfeldt-Lecuona C; Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.

Trends Psychiatry Psychother ; 45: e20230338, 2023.

Article em En | MEDLINE | ID: mdl-34798692

Assuntos

Transtorno Depressivo Maior; Humanos; Inibidor 1 de Ativador de Plasminogênio; Estudos Prospectivos

Palavras-chave

BDNF; Plasminogen activator inhibitor-1; SERPINE1; major depression; meta-analysis; tissue plasminogen activator

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Trends Psychiatry Psychother Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google